Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines
- 1 October 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (15) , 1984-1990
- https://doi.org/10.1016/s0959-8049(00)00192-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell linesBritish Journal of Cancer, 1998
- In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473British Journal of Cancer, 1998
- Recent insights into platinum drug resistance in cancerDrug Resistance Updates, 1998
- AMD473Drugs of the Future, 1998
- Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell linesInternational Journal of Cancer, 1993
- High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.Proceedings of the National Academy of Sciences, 1992
- The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell linesBritish Journal of Cancer, 1991
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexesBritish Journal of Cancer, 1989
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988